Statement on minimum information requirements to advertise the Intanza® 15 mcg vaccine against seasonal influenza

As part of the marketing process of the Intanza® 15 mcg intradermal vaccine against influenza, the High Council for Public Health has issued vaccine recommendation and established the minimum information required for the advertisement of this vaccine, pursuant to article L.5122-6 of the Code of Public Health.

Statement issued by the French Commission of experts on communicable diseases (Commission spécialisée maladies transmissibles), on the proposal of the Technical Vaccination Committee (Comité technique des vaccinations - CTV) on May 28, 2010.

Source: http://www.hcsp.fr/docspdf/avisrapports/hcspa20100528_mmo_intanza15.pdf